Tsimberidou, A., Ma, H., Stewart, C., Schoor, O., Maurer, D., Mendrzyk, R., Satelli, A., Fritsche, J., Stephens, G., Mohamed, A., Hwu, P., Yee, C., Reinhardt, C., Weinschenk, T., Gharpure, K., Stungis, A., Vining, D. J., Singh, H., Walter, S., & Andersson, B. S. (n.d.). 1155PPhase I adoptive cellular therapy trial with ex-vivo stimulated autologous CD8+ T-cells against multiple targets (ACTolog® IMA101) in patients with relapsed and/or refractory solid cancers. Annals of oncology, 29, . http://access.bl.uk/ark:/81055/vdc_100095202810.0x000039